Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Debierre

Showing results (71-80 of 79) with videos related to

Pageof 8
Sort By:
You have reached the last page of results.This site can display upto 79 results.
The Journal of Infectious Diseases|March 17, 2021
Engineering and Functional Evaluation of Neutralizing Antibody Fragments Against Congenital ToxoplasmosisAnne di Tommaso, Matthieu O Juste, Zineb Lakhrif, et al.
The International Journal of Biochemistry & Cell Biology|July 11, 2006
Toxoplasma gondii grown in human cells uses GalNAc-containing glycosylphosphatidylinositol precursors to anchor surface antigens while the immunogenic Glc-GalNAc-containing precursors remain free at the parasite cell surfaceNahid Azzouz, Hosam Shams-Eldin, Sebastian Niehus, et al.
International Journal for Parasitology|March 11, 2018
Imidazo[1,2-b]pyridazines targeting Toxoplasma gondii calcium-dependent protein kinase 1 decrease the parasite burden in mice with acute toxoplasmosisEspérance Moine, Nathalie Moiré, Isabelle Dimier-Poisson, et al.
European Journal of Medicinal Chemistry|October 20, 2015
Development of new highly potent imidazo[1,2-b]pyridazines targeting Toxoplasma gondii calcium-dependent protein kinase 1Espérance Moine, Isabelle Dimier-Poisson, Cécile Enguehard-Gueiffier, et al.
Journal of Immunology (Baltimore, Md. : 1950)|July 10, 2007
Activation of TLR2 and TLR4 by glycosylphosphatidylinositols derived from Toxoplasma gondiiFrançoise Debierre-Grockiego, Marco A Campos, Nahid Azzouz, et al.
JAMA Network Open|February 24, 2026
Morphine Plus Placebo vs Morphine Plus Acetaminophen for Acute Pain in the Emergency Department: A Randomized Clinical TrialGuillaume Cattin, Damien Viglino, Julien Segard, et al.
Journal for Immunotherapy of Cancer|December 1, 2020
<i>Neospora caninum:</i> a new class of biopharmaceuticals in the therapeutic arsenal against cancerLouis Lantier, Agathe Poupée-Beaugé, Anne di Tommaso, et al.
Nucleic Acids Research|July 27, 2012
Sequencing of the smallest Apicomplexan genome from the human pathogen Babesia microtiEmmanuel Cornillot, Kamel Hadj-Kaddour, Amina Dassouli, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|November 26, 2011
Defibrotide interferes with several steps of the coagulation-inflammation cycle and exhibits therapeutic potential to treat severe malariaIvo M B Francischetti, Carlo J Oliveira, Graciela R Ostera, et al.
Pageof 8

Showing results (71-80 of 79) with videos related to

Sort By:
Pageof 8
You have reached the last page of results.This site can display upto 79 results.
The Journal of Infectious Diseases|March 17, 2021
Engineering and Functional Evaluation of Neutralizing Antibody Fragments Against Congenital ToxoplasmosisAnne di Tommaso, Matthieu O Juste, Zineb Lakhrif, et al.
The International Journal of Biochemistry & Cell Biology|July 11, 2006
Toxoplasma gondii grown in human cells uses GalNAc-containing glycosylphosphatidylinositol precursors to anchor surface antigens while the immunogenic Glc-GalNAc-containing precursors remain free at the parasite cell surfaceNahid Azzouz, Hosam Shams-Eldin, Sebastian Niehus, et al.
International Journal for Parasitology|March 11, 2018
Imidazo[1,2-b]pyridazines targeting Toxoplasma gondii calcium-dependent protein kinase 1 decrease the parasite burden in mice with acute toxoplasmosisEspérance Moine, Nathalie Moiré, Isabelle Dimier-Poisson, et al.
European Journal of Medicinal Chemistry|October 20, 2015
Development of new highly potent imidazo[1,2-b]pyridazines targeting Toxoplasma gondii calcium-dependent protein kinase 1Espérance Moine, Isabelle Dimier-Poisson, Cécile Enguehard-Gueiffier, et al.
Journal of Immunology (Baltimore, Md. : 1950)|July 10, 2007
Activation of TLR2 and TLR4 by glycosylphosphatidylinositols derived from Toxoplasma gondiiFrançoise Debierre-Grockiego, Marco A Campos, Nahid Azzouz, et al.
JAMA Network Open|February 24, 2026
Morphine Plus Placebo vs Morphine Plus Acetaminophen for Acute Pain in the Emergency Department: A Randomized Clinical TrialGuillaume Cattin, Damien Viglino, Julien Segard, et al.
Journal for Immunotherapy of Cancer|December 1, 2020
<i>Neospora caninum:</i> a new class of biopharmaceuticals in the therapeutic arsenal against cancerLouis Lantier, Agathe Poupée-Beaugé, Anne di Tommaso, et al.
Nucleic Acids Research|July 27, 2012
Sequencing of the smallest Apicomplexan genome from the human pathogen Babesia microtiEmmanuel Cornillot, Kamel Hadj-Kaddour, Amina Dassouli, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|November 26, 2011
Defibrotide interferes with several steps of the coagulation-inflammation cycle and exhibits therapeutic potential to treat severe malariaIvo M B Francischetti, Carlo J Oliveira, Graciela R Ostera, et al.
Pageof 8